Combined detection of serum exosomal miR-21 and HOTAIR as diagnostic and prognostic biomarkers for laryngeal squamous cell carcinoma - PubMed (original) (raw)
Combined detection of serum exosomal miR-21 and HOTAIR as diagnostic and prognostic biomarkers for laryngeal squamous cell carcinoma
Jingting Wang et al. Med Oncol. 2014 Sep.
Abstract
Serum exosomes containing noncoding RNA (ncRNA) play an important role in both physiological and pathological conditions. However, biological function of exosomal ncRNA remains unclear. The aim of the study was to investigate the prognostic and diagnostic values of exosomal ncRNA by comparing the amounts of exosomal miR-21 and HOTAIR in serum of laryngeal squamous cell carcinoma (LSCC) patients with those of polyps of vocal cords, and by determinating whether combined detection of the two molecules could provide useful information in the diagnosis of LSCC. Exosomes were isolated from the serum samples of 52 LSCC patients and those of 49 patients with polyps of vocal cords. TEM and Western blot were applied for the confirmation of isolated exosomes by observing the ultra structure and testing CD63 marker protein, respectively. RT-PCR was performed to detect the expression of miR-21 and HOTAIR in the exosomes. The receiver-operating characteristic (ROC) curve was generated to examine the prognostic value of the two molecules. The expression of exosomal miR-21 and HOTAIR was significantly higher in patients with LSCC than those with vocal cord polyps. There were significant differences of serum exosomal miR-21 and HOTAIR expressions between the advanced T classifications (T3/T4) or clinical stages (III/IV) and the early stages. The patients with lymph node metastasis had higher serum exosomal miR-21 and HOTAIR expressions than those without. There were no differences between patient sex, tumor locations and differentiations. The area under the ROC curve of combined examination of exosomal HOTAIR and miR-21 for diagnosing LSCC was 87.6 %, which was significantly higher than 80.1 % of miR-21 (p = 0.0359) or 72.7 % of HOTAIR (p = 0.0012), showing 94.2 and 73.5 % of sensitivity and specificity, respectively, in differentiating the malignant from benign laryngeal disease. Serum exosomal miR-21 and HOTAIR were significantly correlated with clinical parameters of LSCC, and combined evaluation of their serum expressions may be a valuable biomarker to screen LSCC and might be a promising predicting tool for LSCC patient.
Similar articles
- Serum miR-632 is a potential marker for the diagnosis and prognosis in laryngeal squamous cell carcinoma.
Cao YC, Song LQ, Xu WW, Qi JJ, Wang XY, Su Y. Cao YC, et al. Acta Otolaryngol. 2020 May;140(5):418-421. doi: 10.1080/00016489.2020.1717610. Epub 2020 Feb 18. Acta Otolaryngol. 2020. PMID: 32068453 - Serum expression of selected miRNAs in patients with laryngeal squamous cell carcinoma (LSCC).
Lucas Grzelczyk W, Szemraj J, Kwiatkowska S, Józefowicz-Korczyńska M. Lucas Grzelczyk W, et al. Diagn Pathol. 2019 May 28;14(1):49. doi: 10.1186/s13000-019-0823-3. Diagn Pathol. 2019. PMID: 31138255 Free PMC article. Clinical Trial. - The Expression of MicroRNA-155 in Plasma and Tissue Is Matched in Human Laryngeal Squamous Cell Carcinoma.
Wang JL, Wang X, Yang D, Shi WJ. Wang JL, et al. Yonsei Med J. 2016 Mar;57(2):298-305. doi: 10.3349/ymj.2016.57.2.298. Yonsei Med J. 2016. PMID: 26847279 Free PMC article. - Exosomal microRNA panels as biomarkers for hematological malignancies.
Moloudizargari M, Hekmatirad S, Mofarahe ZS, Asghari MH. Moloudizargari M, et al. Curr Probl Cancer. 2021 Oct;45(5):100726. doi: 10.1016/j.currproblcancer.2021.100726. Epub 2021 Mar 5. Curr Probl Cancer. 2021. PMID: 33752898 Review. - The Potential Diagnostic Value of Exosomal Long Noncoding RNAs in Solid Tumors: A Meta-Analysis and Systematic Review.
Wu Z, Xu Z, Yu B, Zhang J, Yu B. Wu Z, et al. Biomed Res Int. 2020 Aug 15;2020:6786875. doi: 10.1155/2020/6786875. eCollection 2020. Biomed Res Int. 2020. PMID: 32879887 Free PMC article.
Cited by
- Exosomes: A Source for New and Old Biomarkers in Cancer.
Logozzi M, Mizzoni D, Di Raimo R, Fais S. Logozzi M, et al. Cancers (Basel). 2020 Sep 9;12(9):2566. doi: 10.3390/cancers12092566. Cancers (Basel). 2020. PMID: 32916840 Free PMC article. Review. - Extracellular miRNA-21 as a novel biomarker in glioma: Evidence from meta-analysis, clinical validation and experimental investigations.
Qu K, Lin T, Pang Q, Liu T, Wang Z, Tai M, Meng F, Zhang J, Wan Y, Mao P, Dong X, Liu C, Niu W, Dong S. Qu K, et al. Oncotarget. 2016 Jun 7;7(23):33994-4010. doi: 10.18632/oncotarget.9188. Oncotarget. 2016. PMID: 27166186 Free PMC article. Review. - Exosomes in cancer: small particle, big player.
Zhang X, Yuan X, Shi H, Wu L, Qian H, Xu W. Zhang X, et al. J Hematol Oncol. 2015 Jul 10;8:83. doi: 10.1186/s13045-015-0181-x. J Hematol Oncol. 2015. PMID: 26156517 Free PMC article. Review. - Long noncoding RNAs in head and neck cancer.
Li X, Cao Y, Gong X, Li H. Li X, et al. Oncotarget. 2017 Feb 7;8(6):10726-10740. doi: 10.18632/oncotarget.12960. Oncotarget. 2017. PMID: 27802187 Free PMC article. Review. - Exosomal lncRNA HCG18 contributes to cholangiocarcinoma growth and metastasis through mediating miR-424-5p/SOX9 axis through PI3K/AKT pathway.
Ni Q, Zhang H, Shi X, Li X. Ni Q, et al. Cancer Gene Ther. 2023 Apr;30(4):582-595. doi: 10.1038/s41417-022-00500-2. Epub 2023 Feb 28. Cancer Gene Ther. 2023. PMID: 36854894 Free PMC article.
References
- Clin Chem. 2010 Nov;56(11):1733-41 - PubMed
- Crit Rev Oncol Hematol. 2011 Nov;80(2):193-208 - PubMed
- Am J Pathol. 2013 Jan;182(1):64-70 - PubMed
- Oncol Rep. 2014 May;31(5):2029-34 - PubMed
- Eur J Cancer. 2010 Dec;46(18):3409-16 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous